As of 2025-05-07, the Intrinsic Value of Medtronic PLC (MDT) is 109.91 USD. This Medtronic valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 82.32 USD, the upside of Medtronic PLC is 33.50%.
The range of the Intrinsic Value is 67.26 - 250.24 USD
Based on its market price of 82.32 USD and our intrinsic valuation, Medtronic PLC (MDT) is undervalued by 33.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 67.26 - 250.24 | 109.91 | 33.5% |
| DCF (Growth 10y) | 82.93 - 278.44 | 128.82 | 56.5% |
| DCF (EBITDA 5y) | 80.34 - 111.15 | 93.91 | 14.1% |
| DCF (EBITDA 10y) | 93.83 - 135.70 | 112.08 | 36.2% |
| Fair Value | 16.60 - 16.60 | 16.60 | -79.83% |
| P/E | 86.92 - 135.79 | 111.69 | 35.7% |
| EV/EBITDA | 80.50 - 125.03 | 104.92 | 27.4% |
| EPV | 58.52 - 87.91 | 73.22 | -11.1% |
| DDM - Stable | 33.36 - 125.96 | 79.66 | -3.2% |
| DDM - Multi | 62.53 - 170.42 | 90.00 | 9.3% |
| Market Cap (mil) | 105,578.70 |
| Beta | 0.33 |
| Outstanding shares (mil) | 1,282.54 |
| Enterprise Value (mil) | 130,945.70 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.67% |
| Cost of Debt | 4.39% |
| WACC | 6.92% |